PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportscomplex partial epilepsy
MeSH D017029 - complex partial epilepsy
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D004828:Partial epilepsies
145 Companies
20 Drugs
$
Success rate
D017029: 
Complex partial epilepsy
68 Companies
7 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaCarbamazepine Carbamazepine  2012-09-20   
Carbamazepine Epitol  1986-09-17   
Vigabatrin Vigabatrin  2019-01-14   
Taro PharmaceuticalCarbamazepine Carbamazepine  1996-10-03   
Carbamazepine Teril  2003-09-26   
CiplaVigabatrin Vigabatrin  2019-12-03   
NovartisCarbamazepine Tegretol  1982-01-01   
TakedaCarbamazepine Carbatrol  1997-09-30   
Aurobindo PharmaVigabatrin Vigabatrin  2021-09-29   
Dr Reddys LaboratoriesVigabatrin Vigabatrin  2018-11-20   
Zydus TherapeuticsCarbamazepine Carbamazepine  2019-02-07   
Vigabatrin Vigabatrin  2023-03-02   
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
0%
0/1
Phase 3
70%
7/10
Approved: 6Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Carbamazepine,
Divalproex sodium
Mylan
Divalproex sodium,
Bevifimod
Novartis
Carbamazepine,
Benzodiazepine,
SELURAMPANEL
Dr Reddys Laboratories
Divalproex sodium
1
2
3
4
5
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use